Myeloma Paper of the Day, July 24th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: United Kingdom Biobank Pharma Proteomics Project finds predictive performance of sparse models (5-20 proteins) was superior to models developed using clinical information for 67 pathologically diverse diseases including myeloma.”
Source: Robert Orlowski/X
Proteomic signatures improve risk prediction for common and rare diseases
Authors: Julia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, Praveen Surendran, Damien C Croteau-Chonka, Chloe Robins, Ana Torralbo, Christopher Tomlinson, Florian Grünschläger, Natalie Fitzpatrick, Cai Ytsma, Tokuwa Kann, Stephan Gade , Daniel Freitag, Frederik Ziebell, Simon Haas, Spiros Denaxas, Joanna C Betts, Nicholas J Wareham, Harry Hemingway, Robert A Scott, and Claudia Langenberg.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
